National Center for Advancing Translational Sciences (NCATS) Research & Development Day
Thursday, September 12 2013
9:00 am – 4:30 pm
Location: Novartis Institutes for Biomedical Research, 45 Sidney Street, Cambridge, Massachusetts 02139
We are pleased to announce the inaugural National Center for Advancing Translational Sciences (NCATS) Research & Development Day.
NCATS is seeking strategic partners, including biopharmaceutical companies, venture capital firms, angel investors, foundations, and others to attend our showcase of the therapeutic development projects that have been incubating within NCATS.
Complete event details, including agenda and registration, may be found at: https://events-support.com/events/NCATS_RandD_Day
The goal of the Research & Development Day is to bring together our collaborative partners with the potential investors who will be able to provide the critical financial and technical support to bring these novel therapies to patients. The event will feature presentations by our project partners and NCATS leadership, followed by a networking reception sponsored by Novartis Institutes for Biomedical Research and Pfizer.
The NCATS Division of Preclinical Innovation (DPI) supports preclinical and early clinical development of various therapeutic candidates, through collaborative partnerships with external disease area experts. DPI programs such as Therapeutics for Rare & Neglected Diseases (TRND) and Bridging Interventional Development Gaps (BrIDGs) provide critical scientific and non-dilutive financial resources to move projects forward to filing Investigational New Drug (IND) applications with the Food and Drug Administration (FDA).
If you have additional questions about this event, please contact Neely Gal-Edd (email@example.com).
We look forward to your participation in this exciting event, and invite you to spread the word to other interested colleagues.